Neuroactive steroids and central nervous system disorders

International Review of Neurobiology

Volumn 46, Issue , 2001, Pages 421-459

  Wang, Mingde ^a   Bäckström, Torbjörn ^a   Sundström, Inger ^a   Wahlström, Göran ^a   Olsson, Tommy ^a   Zhu, Di ^a   Johansson, Inga Maj ^a   Björn, Inger ^a   Bixo, Marie ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ALZHEIMER DISEASE; ANIMAL; BRAIN LEVEL; EPILEPSY; FEMALE; HUMAN; MALE; MENOPAUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREMENSTRUAL SYNDROME; REVIEW;

ALZHEIMER DISEASE; ANIMALS; BRAIN CHEMISTRY; EPILEPSY; FEMALE; HUMANS; MALE; MENOPAUSE; PREMENSTRUAL SYNDROME; STEROIDS;

EID: 0035237043     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0074-7742(01)46071-5     Document Type: Article

References (232)

1. Aird, R., and Gordon, G. (1951). Anticonvulsive properties to desoxycorticosterone./4A14 145, 715-779.
2. Almquist, R. (1955). The rhythm of epileptic attacks and its relationship to the menstrual cycle. Ada Neura. Psyrhialr. Srand. 30 (Suppl 105), 7-116.
3. Amandusson, A., Hermansson, O., and Blomqvist, A. (1996). Colocalization of oestrogen receptor immunoreactivity and proenkephalin mRNA expression to neurons in the superficial laminae of" the spinal and medullary dorsal horn of rats. Eur.J. Neurosri. 8, 2440-2445.
4. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edition, pp 714-718. U.S. Department of Health and Human Services, Washington, DC.
5. Appelgren, L. E. (1967). Sites of steroid hormone formation. Autoradiographic studies using labelled precursors. Ada Physiol. Srand. Suppl. 301, 1-108.
6. Asso, D., and Braier, J. R. (1982). Changes with the menstrual cycle in psychophysiological and self-report measures of activation. Biol. P.syrhol. 15, 95-107.
7. Asthana, S., Craft, S., Baker, L. D., Raskind, M. A., Birnbaum, R. S., Lofgreen, C. P., Veith, R. C., and Plymate, S. R. (1999). Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with AlJ.heimer's disease: Results of a placebo-controlled, double-blind, pilot study. Psychoneumerulocrinolngy 24, 657-677.
8. Avis, N. E., Brambilla, D., McKinlay, S. M., and Vass, K. (1994). A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann. Epidemiol. 4, 214-220.
9. Bäckström, T. (1976). Epileptic seizures in women in relation to variations of plasma estrogen and progesterone during the menstrual cycle. Aria Neural. Srand. 54, 321-347.
10. Bäckström, T., and Jorpes, P. (1979). Serum phenytoin, phénobarbital, carbama/epine, albumin, and plasma estradiol and progesterone concentrations during the menstrual cycle in women with epilepsy. Ada Neural. Scand. 59, 63-71.
11. Bäckström, T., Baud, D. T., Bancroft, J., Bixo, M., Hammarbäck, S., Sanders, D., Smith, S., and Zetterlund, B. (1983a). Endocrinological aspects of cyclical mood changes during the menstrual cycle or the premenstrual syndrome. J. Psycho.sam. Obst. Gyn. 2, 8-20.
12. Bäckström, T., Sanders, D., Leask, R., Davidsou, D., Warner, P., and Bancroft, J. ( 1983b). Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psyrhosam. Med. 45, 503-507.
13. Bäckström, T., Zetterlund, B., Bloin, S., and Romano, M. (1984). Effects of continuous progesterone infusion on the epileptic discharge frequency in women with partial epilepsy. Ada Neural. Srand. 69, 240-248.
14. Bäckström, T., Smith, S., Lothian, H., and Baird, D. T. (1985). Prolonged follicular phase and depressed gonadotropins following hysterectomy and corpus lute-ectomy in women with premenstrual tension syndrome. Clin. Endocrinol. 22, 723-732.
15. Bäckström, T., Andersson, A., Baird, D. T., and Selstam, Ci. (1986). The human corpus luteuin secretes 5a-pregnane-3,20-dione. Ada Endorrinologirn 111, 116-121.
16. Bäckström, T., and Hammarbäck, S. (1991). Premenstrual syndrome-Psychiatric or gynecological disorder? Ann. Med. 23, 625-633.
17. Bäckström, T. (1996). Side effects of contraceptives and gonadal hormones. Bfiillit'rc's (ïïniail Psychiatry 2, 715-726.
18. Bäckström, T., Lindhe, B. A., Cavalli-Björkman, B., Nordenström, S., and Hansson. Y. (1992). Effects of oral contraceptives on mood: A randomi/ed comparison of three phasic and monophasic preparations. C.ontmrrplion 46, 253-208.
19. Bäckström, T., Bixo, M., Seippel, I.., Sundström, I., and Wang, VI. D. (1996). Progestins and behavior. In "The Brain: Source and Target for Sex Steroid Hormones" (A. Gena//ani, F.d.), pp. 277-291. Parthenon Publishing, London.
20. Bäckström, T, and Roscisewska, D. (1997). Effects of hormones on sei/ure expression. In "Epilepsy: A Comprehensive Textbook" (J. Engel, Jr. and T. A. Pedlev. Eds.), pp. 2003-2012. Lippincott-Raven Publishing, Philadelphia.
21. Bäckström, T., Appelblad, P., Bixo, M.,Haage, I., Johansson, S., Landgren, S., Seippel, E., Sundstrom, I., Wang, VI. D., and Wahlström, Ci. (2000). Female sex steroids, the brain and behaviour. lu "Mood Disorders in Women" (M. Steiner K. Vonkers, and E. Eriksson, eds.), pp. 189-205. Martin DunitJ. Publishers, London.
22. Badalian, L., Temin, P. A., and Muhin, R. I. U. (1991 ). Obtained effect of testenat treatment of epilepsy in men. Y.h. \'nl>alol. I'sikhiah: 91, 44-47.
23. Baldereschi, M., Di Carlo, A., Lepore, V., Bracco, L., Maggi. S., Grigoletto, F., Scarlato, Ci., and Amaducci. L. ( 1998). Eslrogen-replacement therapy and Al/heimer's disease in the Italian Longitudinal Study on Aging. \ri
24. Ballinger, C. B. (1990). Psychiatric aspects of the menopause. Ht: J. Psychiatry 156, 773-787.
25. Bancroft, J.,Sanders, I)., Warner, P., andLondon, N.. ( 1987). The effects of oral contraceptives on mood and sexuality: Comparison of iriphasic and combined preparations. J. Psycliosom. Obslet. Gynaeatl. 7, 1-8.
26. Banerjee, P. K., andSnead, C. C. (1998). Xeuroactive steroids exacerbate gamma-hydroxvbutyric acid-induced absence seiJ.ures in rats. Eur. f. Pharmacol. 359, 41-18.
27. Barbaccia, VI. L., Concas, A., Serra, M., and Biggio, Ci. ( 1998). Stress and nemosteroids in adult and aged rats.Exf). C.enmtol. 33, 697-712.
28. Barnea, A., Hajibeigi, A., Trant,J. M., and Mason, I. ( 1990). Expression of steroid metaboli/ing en/vines bv aggregating fetal brain cells in culture: A model for developmental regulation of the progesterone 5cv-rediictase pathway. Endocrinology 127, 500-502.
29. Barren-Connor, E., and Rrit/-Silverstein, D. (1993). Estrogen replacement therapy and cognitive function in older women. /AMA 269, 2637-2641.
30. Baulieu, E. E., and Robel, P. (1990). Xeurosteroids: a new brain-function. J. Slemid liiocliein. Mol. Biol. 37, 395-403.
31. Beleih, D., Böiger, VI. B., and Gee, K. W. (1989). Anticonvulsant profile of the progesterone metabolite 5a-pregnan-3o-ol-20-one. Eur. J. I'liarmacol. 166, 325-329.
32. Billiar, R. B., Little, B., Kline, L, Reier, P.,Takaoka,Y., and White, R. J. (1975). The metabolic clearance rate, head and brain extractions, and brain distribution and metabolism of progesterone in the anestheti/ed, female monkey (Macaca inulattfi}. Brain Res. 94, 99-1 13.
33. Bixo, VI., Bäckström. T., Winblad, B., Selstam, Ci., and Andersson, A. (1986). Comparison between pie- and postovulatory distributions of oestradiol and progesterone in the- brain of the PMSG-treated rat. Ada Pliysiol. Scand. 128, 241-246.
34. Bixo, VI., and Bäckström, T. (1990). Regional distribution of progesterone and 5a-pregnane3,20-dione in rat brain during progesterone-induced "anesthesia." I>wc/i(n'um<'ndocrinolf>g\ 15, 159-162.
35. Bixo, M., Bäckström, T., Winblad, B., and Andersson, A. (1995). Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J. Steroid Biochem. mol. Biol. 55, 297-303.
36. Bixo, M., Andersson, A., Winblad, B., Purdy, R. H., and Bäckström, T. (1997). Progesterone, 5apregnane-3,20-dione and 3a-hydroxy-5o'-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res. 764, 173-178.
37. Björn, l., and Bäckström, T. (1999). Compliance to estrogen and progestins in treatment of peri and postmenopausal women. The significance of negative side effects. Maturitas32, 77-86.
38. Björn, I., Bixo, M., Nöjd-Strandberg, K., Nyberg, S., and Bäckström, T. (2000). Negative mood changes during hormonal replacement therapy-A comparison between two different progestins. Am.J. Obstel. C,yn 183, 1419-1426.
39. Boman, K., Bäckström, T., Gerdes, U., and Stendahl, U. (1990). Oestrogens and clinical characteristics in endometrial carcinoma. Anticancer Res. 10, 247-251.
40. Brinton, R. D., Tran, j., Proffitt, P., and Montoya, M. (1997). 17 Beta-estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neumchem. Rex. 22, 1339-1351.
41. Broe, G. A., Henderson, A. S., Greasey, H., McGusker, E., Körten, A. E., Jorm, A. F., Longley, W., and Anthony, J. G. ( 1990). A case-control study of Al/heimer's disease in Australia. Neurology 40, 1698-1707.
42. Broverman, D. M, Klaiber, E. L., Kobayashi, Y, and Vogel, W. (1968). Roles of activation and inhibition in sex differences in cognitive abilities. Psyrhol. Rev. 75, 23-50.
43. Brown, G. S., Ling, F. W., Andersen, R. N., Farmer, R. G., and Areheart, K. L. (1994). Efficacy of depot leuprolide in premenstrual syndrome: Effect of symptom seventy and type in a controlled trial. Obstet, Gynecol. 84, 779-786.
44. Campbell, S. (1976). Double blind psychometric studies on the effects of natural oestrogens on postmenopausal women. In "Managment of the Menopause and the Postmenopausal Years" (S. Campbell, Ed.), pp. 149-158.
45. Cheney, D. L., Uzunov, D., Costa, E., and Guidotti, A, (1995). Gas Chromatographie-mass fragmentographic quantitation of "3or-hydroxy-5ar-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J. Neurosd. 15, 4641-4650.
46. Collins, A., and Landgren, B. M. (1994). Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: A population-based study. Maturilas20 101-111.
47. Goope, J. (1981). Is oestrogen effective in the treatment of menopausal depression? J. R. Coll. Gen. Pmct.Sl, 134-140.
48. Corpechot, C., Young, J., Calvel, M., Wehrey, G.,Veit, J. N., Touyer, G., Mouren, M., Prasad, V. V, Banner, G., Sjovall, J., Baulieu, E. E., and Robel, P. (1993). Neurosteroids: 3c-Hydroxy5o?-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133, 1003-1009.
49. Cotise, J. F.,Lindjey, j., Grandien, K., Gustafsson, J. A., and Korach, K.S. ( 1997). Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptorbeta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 138, 4613-4621.
50. Cullberg, J. (1972). Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with placebo. Ar/ Psychiat. Scand. Suppl. 236, 1-84.
51. Dana-Haeri, J., and Richens, A. (1983). Effect of norethisterone on seizures associated with menstruation. E/jilepsici 24, 377-381.
52. De Lignieres, B., Dennerstein, L, and Backström, T. (1995). Influence of route of administration on progesterone metabolism. MahiritasZl, 251-257.
53. Deiinerstein, L., Burrows, G. D., Hyman, G.J., and Sharpe, K. (1979). Hormone therapy and affect. Matiuitds I, 247-259.
54. Deiinerstein, L., Spencer-Gardner, C., Gotts, Ci., Brown, J. B., Smith, M. A., and Burrows, D. (1985). Progesterone and the premenstrual syndrome: A double blind crossover trial. lit: Med. J. 290, 1617-1621.
55. Dennerstein, I.., Smith, A. M., Morse, C.. Burger, H., Green, A., Hopper, J., and Ryan, M. ( 1993). Menopausal symptoms in Australian women. Med. J. Amt. 159, 232-236.
56. Dhar, V., and Murphy, B. E. (1990). Double-blind randomi/ed crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS). Ps\(honeuroendonïnol<>sr\ 15,489-493.
57. Dickerson,W.(1941). The effect of menstruation on sei/tue incidence. J. Am'. Meut. Dis. 94, 160-169.
58. Ditkoff. E. G.,Grary, W. G., Gristo, M., and lobo, R. A. ( 1991 ). Estrogen improves psychological function in asymptomatic postmenopausal women. Ohslet. (i\iicn>l. 78, 991-995.
59. Drake, E. B.,Henderson, V.,Stancyk, F. Z., McGlearv, G. A., Brown, W. A., Smith, G. A.,RiJo, A. A.,Murdock, G. A., and uckwalter. J.G.(2000). Associations between circulating sex steroid hormones and cognition in normal elderly women. \rumlog\ 54, 599-603.
60. Dubrovsky, B. (2000). The specificity of stress responses to different nocuous stimuli: Xeurosteroids and depression. Hmin Res. Hull. 51, 443-155.
61. Feeler. H. H. (19S4). Hormonesand sexual behavior. Ami. Rev. lyclml. 35, 165-200.
62. Fedor-Frevbergh, P. (1977). The influence of oestrogens on the well-being and mental performance in climacteric and postmenopausal women. Actfi Ol/stet. (J\i/ee
63. Femvick, P., Wheeler, M., Brouwn, S., and Toone, B. ( 1989). The effect of subcutaneous testosterone implants in patients with deficiency and epilepsy. Abstract Bmik: ISth Iiiteniulioiidl Congress oj Xeii' Delhi.
64. Fettes, 1. (1997). Menstrual migraine. Methods of prevention and control. Postgrad. Med. 101, 67-70, 73-7.
65. Fillit, H., Weinreb, H., Gholst, I., Lnine, V.. McEwen. B.. Amador. R., and abriskie, J. (198(5). Observations in a preliminary open trial of estradiol therapy for senile dementiaAl/heimer's type. Pschoueiiroeuilocriuology 11, 337-345.
66. Foy, M. R., Xu, J., Xie, X., Brinton, R. D.. Thompson, R. F., and Beiger, T. W. (1999).17-betaestradiol enhances XMDA receptor-mediated EPSPs and long-term potentiation. J. Xeurol>lnsiol. 81, 925-929.
67. Ciasior, M., el til. (1997). Anticonvulsant and behavioral effects of' neuroactive steroids alone and in conjunction with diaJ.epam. J. I'/trinnfU'ol. l:\j>. liter. 282, 543-553.
68. Ciee, K.W. (1988). Steroid modulation of the GABA/ben/odia/epine receptor-linked chloride ionophore. Mol.eurobiol. 2, 291-317.
69. Ciinsburg, J., Swinhoe, J., and O'Reilly, B. (1981). Gardiovascular responses during the menopausal hot flush. lir.J. Obstet. C.Miaerol. 88, 925-930.
70. Cioldman, H., Skelley, E. B., Sandman, G. A., Kastin. A.J.. and Murphy. S. (1976). Hormones and regional brain blood flow. Pliurmticul. Kiocliem. Kehiiv5(Suppl 1), 165-169.
71. Ciregoire, A. J, Kumai, R., Everilt, B., Henderson, A. E, and Studd, J. W. (1996). Transdermal oestrogen for treatment of severe postnatal depression. I.mice/ 347, 930-933.
72. Cirudinska, B., and Roscisewska, D. (1980). Dynamics of EEC. changes during the menstrual cycle in epileptic women. Abstract Book of XI Meeting of Polish Xeurological Association in Bydgoszoz.
73. Grunewald, R. A., Aliberti, V., and Panaviotopoulos, G. P. (1992). Exacerbation of typical absence sei/ures by progesterone. Seizure 1, 137-138.
74. Gustalsson, J. A. (2000). An update on estrogen receptors. Seniin Perhuuol. 24, 66-69.
75. Hahn, P. M., Van Vugt, D. A., and Reid, R. L. (1995). A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology 20, 193-209.
76. Hall, S. (1995). Treatment of menstrual epilepsy with a progesterone-only oral contraceptive. Epilepsia 18, 235-236.
77. Hällström, T., and Samuelsson, S. (1985). Mental health in the climacteric. The longitudinal study of women in Gothenburg. Ada Obstet. Gynecol. Scand. Suppl. 130, 13-18.
78. Hammar, M., Lindgren, R., Berg, G. E., Moller, C. G., and Niklasson, M. K. (1996). Effects of hormonal replacement therapy on the postural balance among postmenopausal women. Obstet, fynecol. 88, 955-960.
79. Hammarbäck, S., Bäckström, T., Holst, J., von Schoultz, B., and Lyrenäs, S. (1985). Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement treatment. Ada Obstet. Gynecol. Scand. 64, 393-397.
80. Hammarbäck, S., and Bäckström, T. (1988). Induced anovulation as treatment of premenstrual tension syndrome-A double-blind crossover study with GnRH-agonist versus placebo. Ada Obslet. Gynaecol. Scand. 67, 159-166.
81. Hammarbäck, S., and Bäckström, T. (1989). A demographic study in subgroups of women seeking help for premenstrual syndrome. Ada Obstet. Gynecol. Scand. 68, 247-253.
82. Hammarbäck, S., Damber, J.-E., and Bäckström, T. (1989). Relationship between symptom severity and hormone changes in women with premenstrual syndrome. J. Clin. Endocrinol. Metab.68, 125-130.
83. Hammarbäck, S., Ekholm, U. B., and Bäckström, T. (1991). Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Ada Endocrinol. (Copenhagen), 125, 132-137.
84. Hampson, E., and Kimura, D. (1988). Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behav. Neuwsci. 102, 456-459.
85. Hampson, E. ( 1990). Estrogen-related variations in human spatial and articulatory motor skills. Psychoneuroendocrinology 15, 97-111.
86. Henderson, V. W., Paganini-Hill, A., Miller, B. L., Elble, R. J., Reyes, P. F., Shoupe, D.,McGleary, C. A., Klein, R. A., Hake, A. M., and Farlow, M. R. (2000). Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial. Neurology 54, 295-301.
87. Herkes, G., Eadie, M., Sharbrough, F., and Moyer, T. (1993). Patterns of seizure occurrence in catamenial epilepsy. Epilepsy Res. 15, 47-52.
88. Herzog, A. G. (1986). Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 36, 1607-1610.
89. Herzog, A. G. (1987). Progesterone in seizure therapy [reply to letter]. Neurology 37, 1433.
90. Herzog, A. G., Seibel, M. M., Schomer, D. L., Vaitukaitus, J. L., and Geschwind, N. (1986). Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch. Neural. 43, 341-346.
91. Herzog, A. G. (1991). Reproductive endocrine considerations and hormonal therapy in men with epilepsy. Epilepsia Suppl. 32, 834-837.
92. Herzog, A. G. (1995). Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 45, 1660-1662.
93. Herzog, A. G., Klein, P., and Ransil, B. J. (1997). Three patterns of catamenial epilepsy. Epilepsia 38,1082-1088.
94. Holst, J., Bäckström, T, Hammarbäck, S., and von Schoultz, B. (1989). Progesterone addition during oestrogen replacement therapy effects on vasomotor symptoms and mood. Maturitasll, 13-20.
95. Holte, A. (1992). Influences of natural menopause on health complaints: A prospective study of healthy Norwegian women. Maturitas 14, 127-141.
96. Holzbauer, M. (1971). In vivo production of steroids with central depressant action by the ovary of the rat. Br.J. Pharmacol. 43, 560-569.
97. Honjo, H., Ogino, Y, Naitoh, K., Urabe, M., Kitawaki, J., Yasuda, J., Yamamoto, T., Ishihara, S., Okada, H., and Yonezawa, T. (1989). In vivo effects by estrone sulfate on the central nervous system-Senile dementia (Al/heimer's type)./ Steroid Biochem. 34, 521-525.
98. Hunter, M. S. (1992). The S.E. England longitudinal study of the climacteric and post-menopause. Maturitas 14, 117-126.
99. Isqjärvi, J., Pakarinen, A., and Myllyla, L. (1988). Effects of carbamazepin therapy on serum sex hormone levels in male patients with epilepsy. Epilepsia 29, 781-786.
100. Jacobs, D. M., Tang, M. X., Stern, Y, Sano, M., Marder, K., Bell, K. L., Schofield, P., Doonelef, G., Gurland, B., and Mayeux, R. ( 1998). Cognitive function in nondemented older women who took estrogen after menopause. Neurology 50, 368-373.
101. Jaffe, A. B., Toran-Allerand, C. D., Greengard, P., and Gandy, S. E. (1994). Estrogen regulates metabolism of Al/heimer amyloid beta precursor protein. J. Biol. Chem. 269, 13065-13068.
102. Jasman, L. (1976). In "The Management of the Menopause and Postmenopausal Years" (S. Campbell, Ed.), pp. 11-23. MTP Press, Lancaster.
103. Jones, G. S. (1976). The luteal phase defect. Pert il. Steril. 27, 351-356.
104. Judd, H. L., Judd, G. E., Lucas, W. E., and Yen, S. S. C. (1974). Endocrine function of the post-menopausal ovary: Concentrations of androgens and estrogens in ovarian and peripheral vein blood. J. Clin. Endocrinol. Metab. 39, 1020-1024.
105. Karavolas, H. J., Bertics, P. J., Hodges, D., and Rudie, N. (1984). Progesterone processing by neuroendocrine structures. //J. "Metabolism of Hormonal Steroids in the Neuroendocrine Structures" (F. Celotti, éd.), pp. 149-170. Raven Press, New York.
106. Kaufert, P. A., Gilbert, P., and Täte, R. (1992). The Manitoba Project: A re-examination of the relationship between menopause and depression. Mntunlas 14, 143-156.
107. Kawas, C,., Resnick, S., Morrison, A., Brookmeyer, R.. Corrada, M., Zonderman, A., Bacal, C., Lingle, D. D., and Metter, E. ( 1997). A prospective study of estrogen replacement therapy and the risk of developing Al/heimer's disease: The Baltimore Longitudinal Stud}'of Aging. A>MTO/o£y48, 1517-1521.
108. Kelly, M. J., and Wagner, E. J. (1999). Estrogen modulation of G-protein-coupled receptors. Trends Endocrinol. Metab. 10, 369-374.
109. Kirkham, C., Hahn, P. M., Van Vugt, D. A., Carmichael, J. A., and Reid, R. L. (1991). A randomi/ed, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy. Obstet, (prierai. 78, 93-97.
110. Klaiber, E. L., Broverman, D. M., Vogel, W., and Kobayashi, Y (1979). Estrogen replacement therapy for severe persistent depression in women. Arch. Gen. Ps\rhiatn' 36, 550-554.
111. Klaiber, E. L, Broverman, D. M., Vogel, W., Peterson, L. G., and Snyder, M. B. (1997). Relationships of serum estradiol levels, menopausal duration and mood during hormonal replacement therapy. Psychoneumendocrinology 22, 549-558.
112. Kompoliti, K. (1999). Estrogen and movement disorders. Clin. Neuropharmacol. 22, 318-326.
113. Korkmaz, S., and Wahlström, G. (1997). The EEG burst suppression threshold test for the determination of CNS sensitivity to intravenous anaesthetics in rats, lirnin Kf search (Protocols) 1, 378-384.
114. Korekwa, M. I., and Steiner, M. (1997). Premenstrual syndromes. Clin. Obstet. Gynecol. 40, 564-576.
115. Kraulis, I., Foldes, G., Traikov, H., Dubrovsky, B., and Birmingham, M. K. (1975). Distribution, metabolism and biological activity of deoxycorticosterone in the central nervous system. Brain Res. 88, 1-14.
116. Laidlaw, J. (1956). Catamenial epilepsy. Lancet 271, 1235-1237.
117. Lan, N. C., Gee, K. W., Böiger, M. B., and Chen, J. S. (1991). Differential responses of expressed recombinant human y-aminobutyric acid A receptors to neurosteroids. J. Neurochem. 57, 1818-1821.
118. Landgren, S., Bäckström, T., and Kalistratov, G. (1978). The effect of progesterone on the spontaneous interictal spike evoked by topical application of penicillin to the cat's cerebral cortex. J. Neuwl. Sä. 36, 119-133.
119. Landgren, S., Aasly, J., Bäckström, T., Dubrowsky, B., and Danielsson, E. (1987). The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cortex. Ada Physiol. Srand. 131, 33-42.
120. Levin, E. R. (1999). Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol. Metab. 10, 374-377.
121. Livingstone, S. (1966). Drug Therapy. Charles C Thomas, Springfield, IL.
122. Löfgren, M., Bäckström, T, and Joelsson, I. (1988). Decrease in serum concentration of 5α-pregnane-3,2()-dione prior to spontaneous labor. Arid Obstet. Cynerol. Smnd. 67, 467-470.
123. Logothetis,J., Harner, R., Morrell, F., and Torres, F. (1959). The role of estrogensin catamenial exacerbation of epilepsy. Neurology 9, 352-360.
124. MacNaughton, J., Bangah, M., McCloud, P.,Hee, J, and Burger, H. G. (1992). Age related changes in follicle stimulating hormone, luteinizing hormone, estradiol and imunoreactive inhibin in women of reproductive age. Clin. Endocrinol. 36, 339-345.
125. Magos, A. L., Brewster, E., Sing, R., O'Dowd, T. M., and Studd, J. W. (1986). The effect of norethisterone in postmenopausal women on oestrogen therapy: A model for the premenstrual syndrome. Br. f. Obstet. Cynaeml. 93, 1290-1296.
126. Magos, A. L., Brincat, M., and Studd, J. W. (1986). Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: Placebo controlled study. Br. Med.J. 292, 1629-1633.
127. Marcus, E. M., Watson, C. W., and Simon, S. A. (1968). An experimental model of some varieties of petit mal epilepsy. Electrical-behavioral correlations of acute bilateral epileptogenic foci in cerebral cortex. Epilepsia 9, 233-248.
128. Marder, K., and Sano, M. (2000). Estrogen to treat Alzheimer's disease: too little, too late? So what's a woman to do? Neurology 54, 2036-2037.
129. Mattson, R., Cramer, J., Caldwell, B., and Siconolfi, B. (1984). Treatment of seizures with medroxyprogesterone acetate: Preliminary report. Neurology 34, 1255-1258.
130. Mattson, R., and Cramer, J. (1985). Epilepsy, sex hormones and antiepileptic drugs. Epilepsia 26 (Suppl. 1),S40-S51.
131. Mattson, R. H., Kamer, J. A., Caldwell, B. V., and Cramer, J. A. (1981). Sei/ure frequency and the menstrual cycle: a clinical study [Abstract]. Epilepsia 22, 242.
132. McEwen, B. S., Gould, E., Orchinik, M., Weiland, N. G., and Woolley, C. S. (1995). Oestrogens and the structural and functional plasticity of neurons: Implications for memory, ageing and neurodegenerative processes, dba Foundation Symposium 191, 52-66.
133. McEwen, B. S., Alves, S. E., Bulloch, K., and Weiland, N. G. (1997). Ovarian steroids and the brain: implications for cognition and aging. Neurology 48 (Suppl 7), S8-S15.
134. McEwen, B., and Wooley, C. S. (1994). Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp. Gemntol. 29, 431-436.
135. McKinlay, J. B., McKinlay, S. M., and Brambilla, D. (1987). The relative contributions of endocrine changes and social circumstances to depression in mid-aged women./ Health Sot: Behav. 28, 345-363.
136. McKinlay, S. M., Brambilla, D. J., and Posner, J. G. (1992). The normal menopause transition. Maturitas 14, 103-115.
137. Melcangi, R. C, Celotti, F., Ballabio, M., Castano, P., Massarelli, R., Poletti, A., and Martini, L. (1990). 5a-Reductase activity in isolated and cultured neuronal and glial cells of the rat. Brain Res. 516, 229-236.
138. Metcalf, M. G. (1983). Incidence of ovulation from the nienarche to the menopause. NZ Med. J. 96, 645-648.
139. Mezrow, Ci., Lobo, R., Shoupe, D., Leung, B., Spicer. D., and Pike, M. ( 1994). Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Eertil. Steril. 62, 932-937.
140. Milsom, I., Sundell, G., and Andersch, B. (1991). A longitudinal study of contraception and pregnancy outcome in a reprecentative sample of young Swedeish women. Contraception 43,111-119.
141. Molnar, Ci. W. (1975). Bodv temperature during menopausal hot flashes. J. Appl. Ph\siol. 1, 499-503.
142. Vlonroe,S. E., Jaff'e, R. B.,and Midgley, A. R. (1972). Regulation of human gonadotropins. XIII. C Changes in serum gonadotropins in menstruating women in response to oophorectomv. J. Clin. Eudoninol. Metab. 34, 420-422.
143. Montgomery,C., Appelby, L., Brincat, M., Versi, E., Tapp, A., Ferwitk, P. B., and Studd, J. W. (1987). Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 7, 297-299.
144. Morrow, A. L., Devaud, L. L., Purdy, R. H., and Paul, S. M. (1995). N'euroactive steroid modulators of the stress response. Ann. NY Acad. Sei. 771, 257-272.
145. Mortola, J. F., Girton, L., and Fischer, L'. (1991). Successful treatment of severe premenstrual syndrome bv combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J. Clin. Endocrinol. Metab. 71, 252A-252F.
146. Moss, R. L., and Gu, Q. (1999). Estrogen: Mechanisms for a rapid action in GA1 hippocampal neurons. Steroids 64, 14-21.
147. Motta, E., and Roscisewska, D. (1980). The effect of gonadal hormones in the treatment of epilepsy. Proceedings of XIV Meeting of Polish neurological association. Bydgos/c/: Abstract book; 121.
148. Mulnard, R., Cotman, G. W., Kawas, G., van Dyck, G. H., Sano, M.. Doodv, R., Koss, E., Pfeiffer, E.,Jin, S., Ciarnst, A., Grundman, M., Thomas, R., and Thal, L.J. (2000). Estrogen replacement therapy for treatment of mild to moderate Al/heimer's disease: A 1-year randomiJ.ed controlled trial. JAMA 283, 1007-1015.
149. Munari, C",., Gasaroli, D., MatteuzJ.i, G., and Pacifico, E. (1979). The use of Althesin in drugresistant status epilepticus. Epilepsia 20, 475-484.
150. Murphy, D. D., and Segal, M. (1996). Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J. Neumsci. 16, 4059-4068.
151. Xaessén, T., Persson, J., Adami, H., Bergström, R., and Bergkvist, E. ( 1990). Hormone replacement therapv and the risk for first hip fracture. Ann. Intern. Med. 113, 95-103.
152. Ohkura, T, Isse, K., Akaawa, K., Hamamoto, M., Yaoi, Y, and Hagino, N. (1994). Low-dose estrogen replacement therapy for Al/heimer-disease in women. Menopause 1, 125-130.
153. Ohkura, T., Isse, K., AkaJawa, K., Hamamoto, M., Yaoi, Y, and Hagino, N. (1995). Long-term estrogen replacement therapy in female-patients with dementia of the al/heimer-tvpe-7 case-reports. Dementia 6, 99-107.
154. Paganini-Hill, A., and Henderson, V. VV. (1994). Estrogen deficiency and risk of Al/heimer's disease in women. Am. J. Epidemiol. 140, 256-261.
155. Paganini-Hill, A. ( 1996). Oestrogen replacement therapv and Alzheimer's disease. Kr. J. Obstet. Gynaecol. 103 (Suppl 13), 80-86.
156. Palacios, S., Gifuentes, I., Menendez, G., and von Heide, S. (2000). The central nervous svstem and HRT. Inl.J. 1-ertil. \\omens Med. 45, 13-21.
157. Patkai, P., Johannson, G., and Post, B. (1974). Mood, alertness and svmpathetic-adrenal medullary activity during the menstrual cvcle. Pschosom. Med. 36, 503-512.
158. Pau, K. Y, and Spies, H. ( 1998). Putative estrogen receptor beta and alpha mR\A expression in male and female Rhesus macaques. Mol. Cell. Endocrinol. 25, 59-68.
159. Paul, S. M., and Purdy, R. H. (1992). Neuroactive steroids. FASEBJ. 6, 2311-2322.
160. Persson, I., Adami, H. O., Bergkvist, L., Lindgren, A., Pettersson, B., Hoover, R., and Schairer, C. ( 1989). Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: Results of a prospective study. Br. Med.J. 298, 147-151.
161. Phillips, S. M., andSherwin, B. B. (1992a). Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17, 485-495.
162. Phillips, S. M., and Sherwin, B.B. (1992b). Variations in memory functions and sex sferoid hormones across the menstrual cycle. Psyrhoneuroendocrinology 17, 497-506.
163. Pickerodt, V., McDowal, D. G, Coroneos, N.J., and Keaney, N. P. (1972). Effect of Althesin on cerebral perfusion, cerebral metabolism and intracranial pressure in anestesized baboon. Br.J. Anaesth. 44, 751-757.
164. Prior, J. C., Alojado, N., McKay, D. W., and Vigna, Y M. (1994). No adverse effects of medroxyprogesterone treatment without estrogen in pastmenopausal women: Double blind, placebo-controlled, crossover trial. Obstet, Cynecol. 83, 24-28.
165. Puia, G., Santi, M., Vicini, S., Pritchett, D. B., Purdy, R. H., Paul, S. M., Seeburg, P. H., and Gosta, E. (1990). Neurosteroids act on recombinant human GABAA receptors. Neuron 4, 759-765.
166. Purdy, R. H., Moore, P. H., Jr., Rao, P. N., Hagino, N., Yamaguchi, T., Schmidt, P., Rubinow, D. R., Morrow, A. L., and Paul, S. M. (1990). Radioimmunoassay of 3a-hydroxy-5a-pregnan-20-one in rat and human plasma. Steroids 55, 290-296.
167. Purdy, R. H., Morrow, A. L., Moore, P. H.,Jr., and Paul, S. M. (1991). Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Nat. Acad. Sei. USA 88, 4553-4557.
168. Rapkin, A. J., Morgan, M., Goldman, L., Brann, D.W., Simone, D., and Mahesh, V. B. (1997). Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet. Cnecol 90, 709-714.
169. Rauramo, L., Lagerspetz, K., Engholm, P., and Punnonen, R. (1975). The effect of castration and peroral estrogen therapy on some psychological functions. Front. Harm. Res. 3, 94-104.
170. Register, T. C., Shively, G. A., and Lewis, G. E. (1998). Expression of estrogen receptor alpha and beta transcripts in female monkey hippocampus and hypothalamus. Brain Res. 30, 320-322.
171. Resnick, S. M., Metter, E. J., and Zonderman, A. B. (1997). Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect? Neurology 49, 1491-1497.
172. Richardson, S. J., Senikas, V., and Nelson, J. F. (1987). Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J. Clin. Endocrinol. Metab. 65, 1231-1237.
173. Robel, P., Bourreau, E., Gorpéchot, C., Dang, D. G., Halberg, F., Clarke, G., Haug, M., Schlegel, M. L., Synguelakis, M., Vourch, G., and Baulieu, E. E. (1987). Neuro-steroids: 3a-Hydroxy-As-derivatives in rat and monkey brain. J. Steroid Biochem. 27, 649-655.
174. Robel, P., and Baulieu, E. E. (1995). Neurosteroids: Biosynthesis and function. Critical Reviews in Neurobiology 9, 383-394.
175. Rosciszewska, D. (1975). Glinical course of epilepsy in women dependent on puberty, maturity, and climacterium. Neural. Neurochir. Pol. 9, 217-222.
176. Rosciszewska, D. (1980). Analysis of seizures dispersion during menstrual cycle in women with epilepsy. In "Epilepsy. A Clinical and Experimental Research" (J. Majkowaki, Ed.), pp. 280-284. Basel: Karger.
177. Rosciszewska, D., Buntner, B., Guz, I., and Zawisza, L. (1986). Ovarian
178. Rubinow, D. R., Hoban, M. C., Grover, G. N., Galloway, D. S., Roy-Burne, P., Andersen, R., and Merriam, G. R. (1988). Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am.J. Obstet. Gynecol. 158, 5-11.
179. Schmidt, P. J., Purdy, R. H., Moore, P. H., Paul, S. M., and Rubinow, D. R. (1994). Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects.J. Clin. Endocrinol. Metab. 79, 1256-1260.
180. Schmidt, R., Fazekas, F., Reinhart, B., Kapeller, P., Fazekas, G., Offenbacher, H., Eber, B., Schumacher, M., and Freidl, W. (1996). Estrogen replacement therapy in older women: Androstenedione neuropsychological and brain MRI study. J. Am. Geriatr. Soc. 44, 1307-1313.
181. Seippel, L., and Bäckström, T. (1997). Luteal phase estradiol relates to symptom severity between patients with premenstrual syndrome.J. Clin. Endocrinol. Metab. 83, 1988-1992.
182. Selye, H. (1942). Correlations between the chemical structure and the pharmacological actions of the steroids. Endocrinology 30, 437-453.
183. Sherman, B. W., and Korenman, S. G. (1975). Hormonal characteristics of the human menstrual cycle throughout reproductive life.J. Clin. Invest. 55, 699-706.
184. Sherman, B. W., West,J. H., and Korenman, S. G. (1976). The menopausal transition: Analysis of LH, FSH, estradiol and progesterone concentrations during menstrual cycles of older women.J. Clin. Endocrinol. Metab. 42, 629-636.
185. Sherwin, B. B., and Gelfand, M. M. (1985). Sex steroids and affect in the surgical menopause: A double-blind cross-over study. Psychoneuroendocrinology 10, 325-335.
186. Sherwin, B. B. (1988). Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13, 345-357.
187. Sherwin, B. B. (1991). The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women.J. Clin. Endocrinol. Metab. 72, 336-343.
188. Sherwin, B. B. (1994). Estrogenic effects on memory in women. Ann. NYAcad. Sei. 743,213-230.
189. Sherwin, B. B. (1997). Estrogen effects on cognition in menopausal women. Neurology 48, 21-26.
190. Shughrue, P. J., and Merchenthaler, I. (2000). Estrogen is more than just a "sex hormone": Novel sites for estrogen action in the hippocampus and cerebral cortex. Front. Neuroendocrinol. 21, 95-101.
191. Skoog, I., and Gustafson, D. (1999). HRT and dementia.J. Epidemiol. Biostat. 4, 227-251.
192. Smith, R. N., Holland, E. F., and Studd, J. W. (1994). The symptomatology of progestogen intolerance. Maturitas 18, 87-91.
193. Smith, S. S. (1989). Estradiol administration increases neuronal responses to excitatory amino acid as a long-term effect. Brain Res. 503, 354-357.
194. Södergard, R., Bäckström, T., Shanbagh, V., and Carstensen, H. (1982). Calculation of free and protein bound fractions of testosterone and estradiol-17 to human plasma proteins at body temperature.J. Steroid Biochem. 16, 801-816.
195. Spiegel, E., and Wycis, H. (1945). Anticonvulsant effects of steroids.J. Lab. Clin. Med. 30, 947-953.
196. Sundblad, C., Modigh, K., Andersch, B., et al. (1992). Clomipramine effectively reduces premenstrual irritability and dysphoria: A placebo-controlled trial. Acta Psychiatr. Scand. 85, 39-47.
197. Sundström, I., Nybergm, S., and Bäckström, T. (1997a). Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17, 370-381.
198. Sundström, I, Aschbrook, D., and Bäckström, T. (1997b). Reduced benzodiazepine sensitivity in patients with premenstrual syndrome, a pilot study. Psychoneuroendocrinology 22, 25-38.
199. Sundström, L, and Bäckström, T. (1998). Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects. Biol. Psychiatry 44, 755-764.
200. Sundström, I., Andersson, A., Nyberg, S., Ashbrook, D., Purdy, R. H., and Bäckström, T. (1998). Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67,126-138.
201. Sveindottir, H., and Bäckström, T. (2000). Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Ada Obstet. Gyn. Scand. 79, 405-413. ;
202. Tang, M. X., Jacobs, D., Stern, Y, Marde, K., Schofield, P., Gurland, B., Andrews, H:, and Mayeux, R. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer disease. Lancet 348, 429-432.
203. Thompson, J., and Oswald, I. (1977). Effect of oestrogen on the sleep, mood and anxiety of menopausal women. Er. Med.J. 2, 1317-1319.
204. Timiras, P. S., and Hill, H. F. (1980). Hormones and epilepsy. In "Antiepileptic Drugs, Mechanism of Action: Advances in Neurology" (G. H. Glaser, J. K. Penry, and D. M. Woodbury, Eds.), Vol. 27, pp. 655-666. Raven Press, New York.
205. Toone, B. (1986). Hyposexuality among male epileptic patients: Clinical and hormonal correlates. In "Aspects of Epilepsy and Psychiatry" (M. R. Trimble and T. G. Bolwig, Eds.), pp. 61-74. John Wiley and Son Ltd, London.
206. Turner, J. M., Coroneos, N. Y, Gibson, R. M., Powell, D., Ness, M. A., and McDowall, D. G. (1973). The effect of Althesin on intracranial pressure in man. Br.J. Anaesth. 45, 186-172.
207. van Duijn, C.M. (1999). Hormone replacement therapy and Alzheimer's disease. Maturitas31, 201-205.
208. Vanhulle, R., and Demol, R. (1976). A double-blind study into the influence of estriol on a number of psychological tests in post-menopausal women. In "Consensus on Menopause Research" (P. A. van Keep, Ed.), pp. 94-99. Lancaster, England: MTP.
209. Vanselow, W., Dennerstein, L., Greenwood, K.M., and De Lignieres, B. (1996). Effect of progesterone and its 5a- and 5/?-metabolites on symptoms of premenstrual syndrome according to route of administration./ Psychosom. Obstet. Gynaecol. 17, 29-38.
210. Verandakis, A., and Woodbury, D. (1963). Effect of cortisol on electroshock seizure threshold in developing rats.J. Pharmacol. Exp. Ther. 139, 110-113.
211. Walker, A., and Bancroft, J. (1990). Relationship between premenstrual symptoms and oral contraceptive use: A controlled study. Psychosom. Med. 52, 86-96.
212. Wang, M. D, Landgren, S., and Bäckström, T. (1997). The effects of allopregnanolone, pregnenolone sulphate and pregnenolone on the CA1 population spike of the rat hippocampus after 17/0-oestradiol priming. Ada Physiol. Scand. 159, 343-344.
213. Wang, M. D., Seippel, L., Purdy, R. H., and Bäckström, T. (1996). Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, pregnenolone sulfate, 5a-pregnan-3,20-dione and 3a-hydroxy-5a-pregnan20-one./ Clin. Endocrinol. Metab. 81, 1076-1082.
214. Wang, M. D., Wahlström, G., Gee, K. W., and Bäckström, T. (1995). Potency of lipid and protein formulation of 5a-pregnanolone at induction of anaesthesia and the corresponding regional brain distribution. Br.J. Anaesth. 74, 553-557.
215. Wang, P. N., Liao, S. Q., Liu, R. S., Liu, C. Y, Chao, H. T., Lu, S. R., Yu, H. Y, Wang, S. J., and Liu, H. C. (2000). Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study. Neurology 54, 2061-2066.
216. Waring, S. C., Rocca, W. A., Petersen, R. C., O'Brien, P. C., Tangalos, E. G., and Kokmen, E. ( 1999). Postmenopausal estrogen replacement therapy and risk of AD: A population-based study. Neurology 52, 965-970.
217. Werboff, L. H., and Havlena, J. (1969). Audiogenic sei/ures in adult male rats treated with vairons hormones, (ifn. C.omp. Eiidocrhiol. 3, 389-397.
218. West, C. P. (1990). Inhibition of ovulation with oral progestins-effectiveness in premenstrual syndrome. EurJ. Obstet. Gynecol. Refmxt. ttiol. 34, 1 19-128.
219. Wong, M., and Moss, R.I. (1994). Patch-clamp analysis of direct steroidal modulation of glutamate receptor-channels. J. Xennieudocriuol. 6, 347-350.
220. Wong, M., Thompson, T.I,., and Moss, R.L. (1996). Nongenomic actions of estrogen in the brain: Physiological significance and cellular mechanisms. C.riliail Rn'invs in Xrum/iivlogv 10,189-203.
221. Wooley, C. S., and McEwen, B. S. ( 1992). Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J. Xeiimsti. 12, 2549-2554.
222. Woollev, C. S., and McEwen, B. S. (1993). Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. ('<>mf>. Xrunil. 336, 293-306.
223. Woollev, C. S., and McEwen, B. S. (1994). Estradiol regulates hippocampal dendritic spine density via an.\-methvl-n-aspartate receptor-dependent mechanism. J. Xi'iim.sci. 14, 7680-7687.
224. Woollev, C. S., Weiland, N. G., McEwen, B. S., and Schwart/kroin, P. A. (1997). Estradiol increases the sensitivity ofTiippocampal CA l pyramidal cells to N M DA receptor-mediated synaptic input: Correlation with dendritic spine density. J. Xcnmsri. 17, 1848-1859.
225. Xu, H., Sweenev, D., Wang, R., Thinakaran, C., Eo. A. C., Sisodia. S. S., Greengard, P., and Gaudy, S. ( 1997). Generation of Al/heimer beta-amyloid protein in the trans-Golgi network in the apparent absence of"vesicle formation. I'rnc. Xatl. Acad. Sri. I'SA 94, 3748-3752.
226. Yaf'f'e, K.,Sawaya, I., Lieberburg, I.,andCradv, D. ( 1998). Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. /AMA 279, 688-695.
227. Vaffe, K., Haan, M., Bvers, A., Tangen, C., and Kuller,I. (2000). Estrogen use, APOE. and cognitive decline: Evidence of gene-environment interaction. Xi'un>/og\ 54, 1949-1954.
228. Yen, S. S., Tsai, C. C.., Naftolin, F., Vanderberg,G., and Ajabar, L. (1972). Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. J. C.lhi. I-'.iidtitritiol Melab. 34, 671-675.
229. Ziel, H. K., and Finkle, W. D. (1975). Increased risk of endometrial carcinoma among users of conjugated estrogens.N.Engl.J. Med. 293, 1 167-1170.
230. Zimmerman, A. W., Holden, K. R., Reiter, E., and Dekaban, A. S. (1973). \ledrox\proges- terone acetate in the treatment of sei/nres associated with menstruation. J. I'edi/ih: 83, 959-963.
231. Zimmerman, E., and Parlée, M. B. (1973). Behavioral changes associated with the menstrual cycle: An experimental investigation. J. Af}j)l. Soc. P.cliol. 3, 335-344.
232. Zweifel, J. E., and O'Brien, W. H. ( 1997). A meta-analysis ol the effect of hormone replacement therapy upon depressed mood. Psyc/ioiieiimi'iitlocriHo/Dgy22 189-212.